The Recall Desk
SevereFDA (Drugs)·D-0365-2015·Announced 2015-01-28

Walgreens Recalls Dopamine Infusions Due to Sterility Assurance Concerns

Walgreens Infusion Services is recalling Dopamine in dextrose due to a lack of sterility assurance. The products were distributed in six states.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating (Score 4) under the rubric, particularly given the risk of infection associated with a lack of sterility assurance in an infusion product.

Plain-English summary

Walgreens Infusion Services is recalling Dopamine in various strengths in dextrose. The recall was initiated due to a lack of sterility assurance for the affected products.

The recalled products were distributed in Texas, Florida, Virginia, Georgia, Louisiana, and Mississippi. All products within their expiry dates are included in this recall.

Healthcare providers and consumers should stop using the recalled products and contact Walgreens Infusion Services for further instructions or a replacement.

The recalled product

Product
Dopamine various strengths in dextrose

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All products within expiry.

Distribution

Distributed in 6 states:

Part of a larger recall action

This product is one of 36 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 36 products in this recall →